Venus Remedies Limited (BOM:526953)

Market Cap	9.88B +159.0%
Revenue (ttm)	7.03B +8.5%
Net Income	762.85M +118.8%
EPS	57.08 +118.9%
Shares Out	13.37M
PE Ratio	12.95
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	830
Average Volume	2,419
Open	747.00
Previous Close	745.05
Day's Range	741.45 - 769.90
52-Week Range	277.85 - 872.80
Beta	0.31
RSI	47.03
Earnings Date	Jan 29, 2026

About Venus Remedies

Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology. The company also offers analgesic, analgesic and antipyretic, antibiotic, anticoagulant, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones (steroid), immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, and solvent products, as well as herbal medicine. The c...

• Industry: Pharmaceutical Preparations
• Founded: 1989
• Employees: 1,298
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 526953

Financial Performance

In fiscal year 2025, Venus Remedies's revenue was 6.48 billion, an increase of 7.72% compared to the previous year's 6.01 billion. Earnings were 453.15 million, an increase of 59.05%.